The General Counsel & Head of Legal will serve as the senior legal advisor to the executive leadership team and Board, with responsibility for designing, implementing, and managing the legal, governance, compliance, and risk management framework
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)